Zacks Investment Research on MSN
Eli Lilly's next-generation obesity drug secures first phase III win
Shares of Eli Lilly LLY rose nearly 2% on Thursday after the company announced that a late-stage study evaluating its ...
Analysts were hoping for a safety profile similar to what was achieved in Phase II but an abnormal sense of touch, called ...
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.4% in the morning session after the company announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results